to help differentiate pulmonary embolism from other lung diseases , we measured the degradation products of fibrinogen and fibrin and soluble fibrin complexes in normal control subjects and patients with pulmonary embolism , lung cancer , pneumonia , chronic obstructive pulmonary disease , tuberculosis , asthma , and several miscellaneous disorders .
C0163275
degradation products
C0015982
fibrin